Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Lossen Rearrangement. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104447451A reveals safer Oseltamivir intermediate synthesis avoiding sodium azide. Enhances supply chain reliability and reduces manufacturing costs significantly.
Novel non-nitration route for m/p-phenylenediamine using phthalate esters. Eliminates explosion risks and waste acid pollution for safer supply chains.
Novel patent CN104447451B offers safer oseltamivir intermediate synthesis avoiding sodium azide with high yield for reliable pharmaceutical intermediates supplier chains.
Patent CN101208292A details a safe, high-yield process for converting hydroxamic acids to amines using alkylphosphonic anhydrides, offering significant cost reduction in amine manufacturing.
Novel synthesis route offers high yield and mild conditions for pharmaceutical intermediates, ensuring supply chain stability and cost efficiency for global buyers.